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Abstract
West-Nile virus (WNV) causes significant morbidity and mortality worldwide. Transplant and
transfusion recipients as well as the elderly are particularly at risk. WNV shows strain variation
from season to season and from locale to locale. This poses a significant problem for diagnosis.
Most assays use a single primer pair to detect WNV by QPCR, and can fail to detect novel stains.
To overcome this limitation, a genome-wide, multiple primer-based real-time QPCR assay was
developed for WNV. The same assay can be used for quantitation, viral variant discovery as well
as for amplification of the entire viral genome using a single annealing temperature. It improves
upon routine diagnosis as well as facilitates laboratory investigations of the pathology of WNV.
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1. Introduction
Since its introduction in 1999, West Nile Virus (WNV) can be detected with a pattern of
significant, recurring and persistent incidences in the U.S. Cases of human infection with
WNV are reported regularly. Transmission requires a mosquito bite or blood transfusion
(CDC, 2004; Hayes et al., 2005; Iwamoto et al., 2003; Pealer et al., 2003). West Nile virus
(WNV) belongs to the Flaviviridae, a family of over 70 related viruses. More specifically,
WNV is a member of the Japaneses Encephalitis (JE) serocomplex, which also includes JE
virus, St. Louis encephalitis (SLE) virus, and Murray Vally enchephalitis (MVE) virus
(Murphy et al., 1995). As with other flaviviruses, WNV is an enveloped single-stranded,
positive sense RNA virus with a genome of approximately 11Kb encoding for three
structural genes and seven nonstructural genes. The genome is translated as a single
polyprotein, which is subsequently cleaved by viral and cellular proteases into its final
products. The earliest complete viral genome sequence for the U.S. epidemic was
determined from the WNV-NY99 isolate (Lanciotti et al., 2002; Lanciotti et al., 1999). This
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genome sequence formed the basis for the first WNV RNA-specific PCR assays (Lanciotti,
Kerst, 2001; Lanciotti et al., 2000; Lanciotti et al., 1999; Shi, 2001; White et al., 2001).
In human patients infected naturally, WNV peripheral blood viral load is generally not
sufficient to allow transmission back into mosquito vectors. Humans are thus the so-called
“dead-end” hosts for this pathogen. Consistent with low-level peripheral viremia in humans,
attempts to isolate live WNV from CSF or serum in culture were generally not successful. A
single study with cancer patients infected experimentally found substantial viral loads in the
peripheral circulation (Southam, Moore, 1954). This leaves PCR-based viral load
determination as the only means to establish acute viral infection or to test blood units for
the presence of the virus.
Since 2003, multiple cases of WNV transmission by blood transfusion have been confirmed
(CDC, 2002; CDC, 2004). One donor positive for anti-WNV antibodies by an IgM capture
ELISA, but the majority of donors who transmitted WNV had not seroconverted at the time
of transmission. In contrast, all donor samples were found positive for WNV by TaqMan™-
based real-time quantitative RT-PCR. The same holds true for clinical observations or
experimental infections in non-human primates (Hukkanen et al., 2006; Ratterree et al.,
2004; Wolf et al., 2006). WNV viremia precedes the IgM antibody response, thus direct
viral load determination by real-time quantitative PCR (qPCR) is the method of choice for
informing clinical decisions as well as public health measures.
Current real-time QPCR WNV assays rely on a single primer pair for viral load
determination as first developed by Lanciotti and colleagues (Lanciotti et al., 2000; Papin et
al., 2004b). They work exceptionally well. Yet, it was hypothesized by our laboratory that
newly emergent WNV strains could have acquired mutations in the PCR primer-binding
sites, which rendered them undetectable to even the best current assays. Furthermore,
additional sequence information is often desirable to aid in the clinical diagnosis or
epidemiological investigations, such as during outbreak inquiries. Thus far these two
different applications, viral load determination and phylogenetic tracking, have necessitated
two completely different assay formats (and twice the amount of sample). A viral-load assay
for WNV is described that uses a single sample preparation/reverse transcription step and
that combines accurate, high throughput quantitation with strain typing capabilities. To
achieve this goal, a novel set of real-time qPCR primers was designed that can be used in
parallel for singleplex viral load assays and that in combination span the entire WNV
genome. RNA isolation/reverse transcription methods were optimized to maximize
sensitivity as well as the number of replicates per sample.
2. Methods
2.1. Virus strains
A plaque-purified low passage (≤5 passages on VERO cells) strain (OK03) was used, which
was isolated from blue jay brains during the 2003 epidemic (Papin et al., 2004b), which
belongs to US lineage I (Davis et al., 2005). NY99 flamingo isolate was used for
comparison (Beasley et al., 2002). Both strains are neuroinvasive and cause 100% mortality
in mice at 103 pfu (Papin et al., 2005).
2.2. RNA isolation and cDNA synthesis
RNA was isolated using RNAzol (Tel-Test, Friendswood, USA) or RNA isolation kit
(Qiagen, Valencia, USA) according to manufacturers recommendations. Total RNA was
reverse transcribed in a 100μl reaction volume containing RNasin, and 0.3 μM of random
hexanucleotide primers (Applied Biosystems, Foster City, USA) according to manufacturers
recommendations. The reaction mix was incubated sequentially at 42 °C for 45 min, 52 °C
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for 30 min, and 70 °C for 10 min. The reverse transcription reaction was stopped by heating
to 95 °C for 5 minutes. All liquid was then collected at the bottom of the tube by
centrifugation at 16,873 × g for 3 minutes. Next, 0.5 U RNase H (Invitrogen, Carlsbad,
USA) was added, and the reaction was incubated at 37 °C for 30 min and again heated to 95
°C for 5 min. Afterwards, the cDNA pool was chilled on ice, collected at the bottom of the
tube and stored at −80 °C.
2.3. Real-time quantitative PCR
Real-time qPCR was conducted using 2xSYBR mix (Roche Applied Science, Indianapolis,
USA) using a final primer concentration of 150 nM. Gradient Real-time qPCR was
performed with an MJR Opticon2 unit with hot-start (5 min 95°C) and the following cycling
conditions (15 sec 95°C, 15 sec gradient 55-65°C, 15 sec 68°C for 40 cycles). Cycle
threshold (CT) values were determined by automated threshold analysis. QPCR was set up
in a dedicated room using a RoBoGo™ pipetting robot (MWG, Alabama, USA) with liquid
level sensing, allowing for a pipetting accuracy of 0.1 μl. All surfaces were cleaned daily
with 10% bleach, and exposed to UV lights overnight. Designated gowns, gloves, and
facemasks were worn for all work. Dissociation curves were recorded after each run and the
amplified products were visualized by 2% agarose gel electrophoresis.
2.4. PCR product cloning and sequence analysis
PCR products were purified using Qiagen PCR extract kit (Qiagen, Valencia, USA). The
ends were repaired using End-It repair kit (Epicentre, Madison, USA) and ligated to EcoRV-
cut, dephosporylated pbluescriptSKII+ (Stratagene, La Jolla, USA) at 14 °C overnight using
T4 ligase (NEB, Ipswich, USA). Ligation mixes were transformed into DH5alpha bacteria
and plated on IPTG/X-gal plates (Invitrogen, Carlsbad, USA). Multiple positive clones were
sequenced in both directions using M13 forward and reverse primers. The complete
sequence of WNV OK03 has been deposited in genbank (accession number EU155484).
2.5. SNP mapping
84 complete WNV genomes were aligned to the NY-99 flamingo isolate (accession#
AF196835) and identified all SNPs using Sequencer v4.8 (Gene Codes Corp., Ann Arbor,
USA). The number of intervening nucleotides between any two adjacent SNPs was
calculated. Graphs were produced in R version 2.5.1.
3. Results
3.1. A genome-wide SNP map of WNV evidences substantial variation
To test the hypothesis that single nucleotide polymorphisms (SNPs) are present in recent
WNV isolates and that SNPs may be present in any single one PCR primer binding site that
is used for diagnosis, genbank was queried. 1,628 SNPs out of 11,029 nucleotide positions
were found by BLAST search of the prototypical lineage I strain AF196835 (Figure 1A). Of
those 82 sequences the medium number of SNPs per genome was 34 with a range of 0-499
SNPs. The SNPs were distributed evenly across the genome, except for the 3′ and 5′ UTR
regions (Figure 1B, D), which exhibited a relative paucity of SNPs. The E orf, too,
contained numerous SNPs, which were distributed across the length of the orf (Figure 1C).
This is a conservative estimate, since only genbank entries classified as containing complete
WNV genome sequences were included in our alignment and of those only n=82 sequences
with less than 500 mismatches (Figure 1F). For instance, strain AF196835 shows more than
2000 vis-à-vis strains belonging to other lineages such as lineage II, AY532665; lineage III,
AY765264; lineage IV, AY277251; and lineage V, DQ256376). Moreover, strains classified
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as lineage I-B (D00246), show more than 1000 mismatches when aligned against the
AF196835 sequence.
To gain a more detailed view at the SNP distribution, the nucleotide distances between any
two adjacent SNPs were calculated (Figure 1E). The mean distance between any two SNPs
in the WNV genome was 6.75 nucleotide with a 95CI of 6.46 - 7.05 and a range of 0 - 54
nucleotides. Since a QPCR amplicon averages 90-200 nucleotides, it can be expected that
diagnostic tests based upon only a single PCR assay will, sooner or later, fail because of
SNPs in either one of the primer or the probe binding sites.
The 5′UTR up to nucleotide 420 and the 3′ UTR up to nucleotide −513 contained large
inter-SNP regions, indicative of sequence conservation. This was expected since these
regions are conserved among WNV and other flaviviruses in general. Both St. Louis
encephalitis virus (SLE) and Japanese encephalitis (JEV) share extensive sequence identity
in the UTR regions of up to 81% for SLE isolate BeAn 247377 (accession # EF158067) and
up to 78% for JEV isolate K01-JN (accession# AY965851) for the 5′ UTR, respectively.
Hence, for the purpose of differential WNV detection, primers that target the UTR regions
are expected to have low specificity.
In the U.S. the possibility of misclassifying an infection as SLE rather than WNV raises
concerns. Additionally, viral UTRs should not be selected as targets for diagnostic PCR
probes due to the fact that UTR regions exhibit extensive and stable secondary structures.
For the purpose of WNV detection, these may not be efficiently transcribed by reverse
transcriptase or not unfold completely during the short denaturation step of recent “fast”
real-time QPCR protocols. Hence, primers that target the UTR regions are expected to have
low sensitivity. In sum, there are few absolutely conserved regions in the WNV genome and
targeting them may not yield the best assay. It can be expected that there exist WNV
sequence variants that escape detection with current single primer-pair-based assays.
3.2. A novel set of WNV primers validated by annealing temperature profiling
One approach to overcome potential false negative results caused by single mutations within
any viral genome is to use multiple primers against the same virus. To test this hypothesis a
panel of novel WNV-specific QPCR primers were developed with equal sensitivity as well
as an integrated, high throughput assay format that reduce greatly false negative rates.
The chief concern when using multiple primers against the same target is that primers may
exhibit varying annealing temperatures and thus cannot be combined on a single plate in a
96 or 384 well format. “PrimeTime” is based on Primer3 (Rozen, Skaletsky, 2000) to design
multiple primers against WNV that share the same melting temperature (Tm) and are
compatible with each other. The initial primer design strategy which was used imposed no
limitations as to the location of a given primer, it only required strict adherence to Tm and
universal primer design parameters (Papin et al., 2004a). This approach identified multiple
primers across the WNV genome (Table 1).
QPCR optimization typically evaluates primer concentration, Mg2+ concentration and
annealing temperature. First, the influence of the primer concentration was evaluated. All
primers yielded single QPCR products with comparable efficiency (Keff.) at 150 nM final
concentration, consistent with our prior experience using real-time QPCR arrays of >80
primers for human herpesviruses (Dittmer, 2003; Dittmer et al., 2005; Fakhari, Dittmer,
2002; Hilscher et al., 2005). Adjusting reagent conditions, such as Mg2+ concentration
individually for each primer pair is impractical as it limits high throughput, automated
analyses with multiple primers per target. It was not necessary here, since all primer pairs
designed according to our parameters performed equally at a given Mg2+ concentration (data
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not shown). Therefore, the reagents provided in the commercial 2x SYBR mix were used. It
canhypothesized, however, that one reason for decreased primer pair efficiency was a
suboptimal annealing temperature under our QPCR conditions. Tm predictions (Cantor,
Schimmel, 1980) as provided by most primer design programs are not accurate, since the
exact salt concentrations and buffer composition of most commercial QPCR reagents are not
available. To test this hypothesis the gradient feature of the Opticon2 (MJR research/Biorad
Inc.) real-time QPCR unit was used, which combines gradient PCR with the capability to
record product accumulation quantitatively in real-time in the standard 96 well format.
Hence, an annealing temperature dependent change in performance can be quantified on the
same plate without post-PCR processing. Next a gradient annealing step of 55°C to 65°C for
15 sec. followed by a 68°C 15 sec. extension step, followed by fluorescence measurements,
followed by a 94°C 10 sec denaturing phase was employed. Fluorescence in each well was
always measured at the same temperature. Hence, the resulting CT values reflect primarily
differences in annealing efficiency. Other factors include primer extension efficiencies, the
formation of primer dimmers, the formation of primer hairpins, template stability (including
GC content), and template secondary structure (such as hairpin formation), among others,
but not temperature dependencies during the extension phase or dye intercalation. Using
automation, the optimal annealing temperature for sixteen primers pairs across six
temperature points were determined at the same time. Most combinations of primers with a
Primer3-predicted Tm of 60°C showed amplification at 60°C, but that temperature profiles
varied considerably among individual primer pairs. Figure 2, panel A exemplifies a very
efficient primer pair, as indicated by a median CTmedian= 10 with little variation across the
annealing temperature range. Figure 2, panel B shows a less efficient primer pair, as
indicated by CTmedian= 13.5, but with likewise little variation across the annealing
temperature range. Figure 2, panel C shows a still less efficient primer pair, as indicated by
CTmedian= 23.5. It showed little variation across a wide annealing temperature range. By
contrast, Figure 2, panel D shows a primer pair with a strong annealing temperature
dependence as evidenced by a continuously changing CT between the lowest and highest
annealing temperature. Figure 2, panel E shows a primer pair with a higher annealing
temperature dependence. It failed to function above 64°C. In sum, many primer
combinations functioned equally efficiently within ±2°C of their predicted Tm. Thus assays
using multiple primer pairs against the same target, WNV, can be combined on the same
instrument and 96 or 384 well plate.
After 40 cycles, all products for a given primer pair yielded the same size single band on an
agarose gel and the same single peak melting temperatures (data not shown). This was
expected since the primer design program incorporated a BLAST (Altschul et al., 1997)
step, which excluded primers that bound anywhere other than the intended targets (Dittmer
et al., 2005). This evidence confirms that a change in annealing temperature did not yield to
a change in product, but reflected purely the efficiency of primer annealing.
Absolute quantitation using an external standard is required for viral copy number
determination, as amplification efficiencies between primer pairs can vary considerably. Of
note, the two worst performing primer pairs (Figure 2, C and E) also yielded considerably
longer qPCR products of 2651 bp and 2282 bp, respectively, which under fast qPCR cycling
protocols as are used here (extension ≤30sec) are associated with lower qPCR efficiency. A
linear relationship (p≤0.005, by regression analysis) between amplicon length and median
CT (Figure 3) was evident for amplicon lengths above 500 bp. For amplicon length below
500 bp, performance in qPCR was not dependent on amplicon length. The degree of
annealing temperature variation was not dependent on amplicon length, since large
interquartile differences were observed for the smallest (42 bp) as well as for larger (486 bp,
1042 bp, 2281 bp) amplicons. This shows that amplicon length can limit assay sensitivity for
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the detection of WNV and that an amplicon size of 500 bp or less is associated with higher
sensitivity.
3.3. An optimized, equal amplicon size, equal annealing temperature, and equal efficiency
set of WNV primers for viral load determination and phylogenetic analysis
To address the issue of amplicon length dependent changes in primer efficiency, i.e. assay
sensitivity, a subset of real-time qPCR primer pairs were chosen that all yielded a 400bp
product (Figure 4A), and that exhibit a temperature invariant annealing temperature profile
around 60±5°C (data not shown) under rapid qPCR cycling conditions. An amplicon length
of 400 bp was chosen because (a) these can be easily purified by commercial, high-
throughput resin-based methods, while smaller amplicons such as the typical ≤ 90bp
TaqMan™ amplicons do not bind efficiently to DNA affinity resins (Qiagen, and Promega
product information and unpublished observation); and (b) direct sequencing of a 400 bp
PCR product yields enough information for strain typing and phylogenic tree construction
with reasonable boostrap values, while the sequence information contained within <100 bp
amplicons does not (Whitby et al., 2003).
None of the primers showed substantial cross reactivity to human cDNA (data not shown).
More importantly, even though one individual primer pair may anneal theoretically
somewhere on the human genome, the pair combinations shown in Figure 4A do not yield
any product when used on human cDNA. The reason is that rapid real-time qPCR conditions
as in Figure 4A do not produce efficiently amplification products larger than 1000 bp and,
based on BLAST search, no two primers used in Figure 4A annealed on the human genome
within even 10,000 bp of each other (data not shown).
By using any three primer pairs from this collection instead of a single primer triplicate
repetition assay format, the false negative rate due to SNPs in one of the primer binding sites
can be reduced 6 fold, while still employing multiple independent QPCR reactions per
sample. In a decision model based on maximal sensitivity, such as to exclude any possibly
WNV positive blood samples, a single positive amplification would cause a sample to be
considered positive. In a decision model weighted towards specificity, such as to exclude
samples that may contain a related flavivirus, three positive amplifications would cause a
sample to be coded positive.
Should the phylogenic information gained from 400 nt not suffice for accurate typing, this
set of WNV QPCR primers can be combined to yield larger PCR products that cover 80% of
the WNV genome (Figure 4B) without change in annealing temperature. This approach was
used to determine the complete sequence of WNV OK03, which has been deposited in
genbank (accession number EU155484). This allows for the sequence determination of
virtually the entire viral genome using the same reagents and annealing temperature as used
for WNV viral load determination. The only change that is necessary is an increase in the
extension time from 30 sec to 120 sec. For completeness, the primer combinations indicated
in Figure 4C can be used to amplify the entire viral genome using a common annealing
temperature of 60 °C and an extension time of 60 seconds. PCRs using first primer (position
1) and the last primer (position 10,876) require an annealing temperature of 55°C.
Typically viral load assays are conducted as replicate measurements of the same assay/
primer pair. Here, the same number of reactions are run but instead of one primer pair
multiple different, but annealing temperatures and Keff.-compatible primer pairs, such as
introduced in Figure 4 are used. This will decreases the false negative rate due to nucleotide
variation in the target sequences of any primer pair. This is particularly applicable to viral
pathogens with seasonal patterns of incidence, such as WNV, since from one season to the
next multiple adoptive mutations can be expected (Davis et al., 2003; Davis et al., 2005).
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3.4. PCR volume optimization contributes significantly to assay sensitivity
As the next step in optimizing high sensitivity, high specificity real-time qPCR assays for
WNV, qPCR volume and input to reaction ratio were evaluated. As expected more sample
per qPCR correlated with higher assay sensitivity, which here is indicated by lower cycle
threshold (CT) numbers (Figure 5A). However, the relationship was not linear, but rather
followed a power decay function. In conclusion, larger reaction volumes ultimately lead to
less efficient heat transfer and thus less efficient PCR. The ratio of input sample to total
reaction volume was more important than overall reaction volume, such that PCRs
comprising only 20% of input sample were much more sensitive (as indicated by lower CT
volumes) than PCRs comprising 42% input sample, even though the total amount of sample
was higher in the latter. At 42%, the cDNA reaction buffer components interfere with the
QPCR buffer components leading to decreased PCR efficiency.
Quadruplicate qPCR yielded standard deviations (SD) of ≤ 1 CT unit, or ≤ 2-fold, regardless
of sample volume. This establishes that quadruplicate measurements suffice to distinguish
two-fold differences in WNV viral load. In this case, too, a power decay function best fit the
data, demonstrating that lower sample volumes were associated with reduced assay
accuracy. The loss in assay accuracy was likely due to increased pipetting error at low
volumes. In sum, an input sample volume of 20 μl in a total qPCR volume of 100 μl yielded
the most sensitive and most accurate real-time qPCR assay for WNV.
3.5. Maximum assay sensitivity by using high volume reverse transcription
Three commercial kits used to isolate WNV RNA were compared: Viral RNA (Qiagen),
HighSensitivity (Qiagen), and viral RNA (Zymogen). All three kits were column-based. It
can be presumed that the column binding capacity to be in excess of any amount of viral
RNA that is found in bodily fluid samples such as plasma, whole blood or CSF. For tissue
samples (bird, biopsy), previously a modified Triazol™ (Sigma) procedure (Papin et al.,
2004b) was used, which has a higher capacity than these column-based kits and eliminates
the risk of overloading as associated with resin/column-based RNA isolation. Furthermore, a
prior reverse transcription assay (Papin et al., 2004b) was compared to the new high-
capacity cDNA kit (Applied Biosystems). The goal was to arrive at a method that maximizes
the number of viral genome cDNA equivalents per well of the QPCR reaction.
The main differences between the different isolation methods were the maximal input
volume and optimal output volumes, which result in the dilution of RNA. Table 1 traces the
effects of volume dilution starting from a theoretical concentration of 1000 copies/ml.
Combining high sensitivity/high input RNA isolation with a high capacity cDNA kit yielded
the most copies (50) as input for qPCR and the most number of possible replicates (nine
+one). If less than 1000 μl input material was available, a low elution volume combined
with customary low volume RT reaction yielded the most copies (12) as input for qPCR
while still allowing triplicate measurements (three+one). Of note the high-sensitivity/high
yield RNA-isolation/reverse transcription combination resulted in a relative amplification of
target copy number during the reverse transcription step. Assuming 1 copy/μl input (or 103
copies/ml titer), after RNA isolation/reverse transcription high yield/high capacity RT
concentrated the RNA to 2.5 copies/μl, while all other combinations diluted the input down
to as much as 0.35 copies/μl in the worst case.
4. Discussion
Absent PCR inhibitors, the most likely source of false negative results for the diagnosis of
RNA viruses, like WNV, is strain variations in the primer target sequence. One strategy to
account for strain variation is to use redundant primers or special PCR conditions, such as
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step-down PCR, which allow the primers to anneal to variant targets. This approach
invariably leads to loss of specificity and may necessitate post-PCR analysis steps. An
alternative approach uses multiple primers against different target sequences of the WNV
genome in parallel under highly stringent qPCR conditions.
A potential problem with using multiple primers is that they may have very different optimal
annealing temperatures. This sparked the development of independently temperature
regulated qPCR systems and gradient PCR. In the case of WNV primers were designed that
do not require specialized equipment because they share the same annealing temperature and
Mg2+ dependencies. Depending on the experimental design these primer either yield
multiple unit size (400 bp) amplicons of equal qPCR efficiency Keff targeted against random
locations of the WNV genome, or they can be combined to yield directed, overlapping
amplicons, which span the entire WNV genome.
To measure primer annealing efficiency (Figure 2), a gradient annealing step was used
followed by a high temperature extension step to optimize polymerase activity, followed by
fluorescence measurements at high temperature to minimize background. This protocol
results in reliable annealing temperature determination for a given reagent mix. Annealing
temperature did not depend on primer or target concentration (data not shown). It has been
shown previously that raising the annealing temperature from the universal, two-step cycling
conditions of 60°C to 62°C, absent any other changes, lowered the rate of false-positive
signals for primer pairs with equal efficiency at higher temperature (Hilscher et al., 2005),
even though the primers were designed using TaqMan™ assay parameters (Applied
Biosystems), which specify an annealing temperature of 60°C. Alternatively, a gradient two-
step protocol could be used to optimize the annealing temperature. This would use the same
gradient annealing step of 55°C to 65°C for 30 seconds, followed by fluorescence
measurements at the annealing temperature, followed by a 94°C 10 seconds denaturing
phase. Fluorescence would be measured at different temperatures and the resulting
quantitation would reflect differences in primer annealing efficiency as well as temperature
dependencies of both the polymerase and of the dye intercalation. The latter experimental
design, while also arriving at optimal conditions, does not lend itself to rational explanation
of the contribution of individual parameters to the overall reaction.
It was shown previously that an intercalating dye-based real-time QPCR assay is as sensitive
as TaqMan™-based real-time QPCR for WNV (Papin et al., 2004b). The use of an
intercalating dye such as SYBRgreen™ as a method of detection has three principal
advantages. First, it is more economical, since no doubly-labeled primer has to be
synthesized and SYBR-containing commercial 2x qPCR mixes cost the same as non-
SYBR™-containing commercial 2x qPCR mixes. Second, SYBR™-based qPCR can detect
WNV strain variants with mutations in the target site, which prevent annealing of the
TaqMan™ probe (Papin et al., 2004b). Third, SYBR™-based qPCR no longer requires Taq-
polymerase-associated 5′nuclease activity and can be used with 3′proof-reading (“high-
fidelity”) polymerases as well as polymerases that are active a higher extension
temperatures.
Clearly, there is a trade off between sensitivity and specificity. The design described above,
which incorporates a BLAST search of primer pairs rather than single primers, found them
to be highly specific for WNV. The exception here is primer 10881r, since this primer marks
the 3′ end of WNV, which of course is conserved among many flaviviruses. In case of true
cross reactivity, our method of using multiple WNV primer pairs in parallel against the same
sample will yield a discordant read-out and thus alert the operator to the possibility of cross
reactivity. By contrast a simple, single primer-pair based assay either fails completely (in
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case of sequence variation of a new WNV isolate) or yields a false positive in case of cross
reactivity to a related flavivirus.
In addition to novel primer sets, other aspects of assay design were optimized. Careful
optimization of the pre-PCR steps can boost sensitivity by as much as 20 fold (table 2).
Since column-based RNA purification protocols lose efficiency if the elution volume is
reduced, scaling up the RT reaction to accommodate 50 μl of input RNA provides the best
approach to maximize sensitivity. Similarly, optimizing the qPCR volume (Figure 5)
contributes to overall assay sensitivity.
Currently many real-time qPCR assays for WNV viral load determination are in use and
many have been adopted for high throughput screening (Eisler et al., 2004; Lanciotti et al.,
2000; Papin et al., 2004b; Shi, 2001; Tewari et al., 2004; Vanlandingham et al., 2004). Still,
they can be improved upon. As WNV incidence rates in the U.S.A. change from an
epidemic pattern to a more variable and more seasonable endemic pattern, the new assay
format presented here may prove its utility. The blood supply for the general population is
not screened for WNV, which reflects primarily economic considerations (Busch et al.,
2005; Stramer et al., 2005). However, major transplant centers screen donor blood and
organs used in transplantation, since WNV can cause serious illness and mortality in
immune compromised patients (Armstrong et al., 2003; Cushing et al., 2004; Hayes et al.,
2005; Iwamoto et al., 2003; Murtagh et al., 2005; Pealer et al., 2003). The required
throughput is lower. The need for increased sensitivity and the need to detect newly
emerging strain variants can be filled with the genome-wide targeted real-time qPCR assay
presented here.
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SNP distribution across the WNV genome. Panel A-D SNP positions are indicated by a
black bar. A, distribution across the entire genome; B, distribution across the most 5′ 1,529
nucleotides; C, distribution across the E orf; D, distribution across the most 3′ 1,529
nucleotides. E, plot of the between SNP distances on the vertical against the SNP position on
the horizontal axis across the entire 11,029 WNV genome (genbank accession # AF196835).
F, Frequency histogram of the distributions of SNPs per genome. G, Distribution of base
calls counted as SNP. Letters follow IUBMB nomenclature. R represents purine (A or G)
and Y represents pyrimidine (T or C).
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Annealing temperature dependence of qPCR for individual primers pair combinations. The
vertical axis is reversed as lower CTs indicate a higher target abundance or, as all reactions
received the same amount of input target a higher qPCR efficiency. The horizontal axis
indicated the annealing temperature. The target was cDNA from WNV strain NY99.
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Amplicon length dependence of qPCR. Boxplot of CT values at different annealing
temperature (vertical axis) for primer pairs of different length (shown on the horizontal
axis). Boxframe indicates the 1 and 3 quartiles, the solid bar the median and whiskers the
minima and maxima. Outliers are indicated by circles. Note that the vertical axis is not to
scale, but categorical.
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Genome-wide qPCR. Picture of an ethidium bromide stained agarose gel yielding same size
amplicons (A) or combinations to yield largers amplicons (B). The primer names are
indicated above the gel. Note that the primer names do not indicate the map position, which
can be obtained from table 1. (C) Shown are the map positions for all primers used in this
study using the West Nile virus strain NY99-flamingo382-99 coordinates (genbank entry
AF196835). Forward primers are above and reverse primers below the genome coordinates.
Primer combinations and amplicon sizes, which were used for sequencing are indicated by
vertical lines.
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Volume dependence of qPCR. (A) Shown on the horizontal axis is the amount of input
cDNA sample and on the vertical axis the mean CT of four replicate measurements after
real-time qPCR. Lower CT corresponds to better detection on a 2log scale. (B) Shown is the
standard deviation (SD) in CT on the vertical and input cDNA volume on the horizontal
axis.
Papin et al. Page 16

























Papin et al. Page 17
Table 1
Primer position, name, orientation and sequence based upon NY99-flamingo382-99, complete genome
(AF196835). SNP positions are underlined.
position name orientation Sequence 5′ to 3′
886 wnv844r −1 CTCCCAAGCATCCAACCAA
10,876 wnv10881r −1 GGGTCTCCTCTAACCTCTAG
10,755 wnv3ncr * −1 CTAGGGCCGCGTGGG
8,292 wnv8293r −1 AGTGGGTTTCTGACCAGTCC
6,041 wnv6042r −1 AGTCGTCTTCATTCGTGTGC
5,783 wnv5784r −1 ATTTTGGGTACTCCGTCTCG
5,092 wnv5093r −1 CTGCACTATCGCGCTTATGT
3,111 wnv3112r −1 TTGACTTCACCCAGAACTGC
2,627 wnv2628r −1 CTGATCGTAGACCGCACACT
2,488 wnv2442r −1 GCTCTTGCCGGCTGATGT
2,463 wnv2464rc −1 TGGCACACCCAGTGTCAGCGTG
2,202 wnv2203r −1 GCTAGTCTCTGCGCTCCTTT
10,090 wnv10091r −1 TGTCATCCACTCTCCTCCTG
1 wnv1f 1 AGTAGTTCGCCTGTGTGAGCTG
10,668 wnv3ncf * 1 CAGACCACGCTACGGCG
1,182 wnv1182t 1 TGCGTGCCCGACCATGGG
1,724 wnv1724f 1 TAGCATTGGGCTCACAAGAG
2,152 wnv2152r 1 CATTGGCACAAGTCTGGAAG
2,158 wnv2158f 1 CACAAGTCTGGAAGCAGCAT
241 wnv521f 1 GCTCTTTTGGCGTTTTTCAG
2,442 wnv2442f 1 GCTCTTCCTCTCCGTGAACG
2,628 wnv2628f 1 AGTGTGCGGTCTACGATCAG
4,605 wnv4605f 1 AAAGAGAGGAGGCGTGTTGT
5,303 wnv5303f 1 AGATGGCTGAAGCACTGAGA
5,304 wnv5304f 1 GATGGCTGAAGCACTGAGAG
5,571 wnv5571f 1 AGGCACTTCAGATCCATTCC
7,809 wnv7809f 1 CAGGAAAGAAGGCAATGTCA
844 wnv844f 1 TGGATCTTGAGGAACCCTGG
865 wnv869t 1 TATGCCCTGGTGGCAGCCGTC
9,604 wnv9404f 1 AAAGGGAAAGGACCCAAAGT
*
previously described in (9).
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Table 2
Theoretical amplification introduced by different RNA isolation and reverse transcription methods (assumes 1
copy WNV genome/μl input or 103 copies/ml)
Step: Zymogen Quiagen Quiagen High
Sensitivity
RNA isolation
input volume 200 μl 200 μl 1000 μl
elution volume 30 μl 50 μl 50 μl
amplification factor 6.6x 4x 20x
copies/μl 6.6 4 20
(1)
Low volume (standard) Reverse transcriptase (RT)
input volume 7 μl 7 μl 7 μl
final volume 20 μl 20 μl 20 μl
amplification factor 0.35x 0.35x 0.35x
copies/μl 2.3 1.4 7
Standard QPCR:
maximal replicates 3+1 3+1 3+1
input volume 5 μl 5 μl 5 μl
final volume 20 μl 20 μl 20 μl
amplification factor 0.25x 0.25x 0.25x
copies/well 12 7 35
(2)
High-capacity Reverse transcriptase (RT)
Input volume 30 μl 50 μl 50 μl
final volume 100 μl 100 μl 100 μl
amplification factor 0.33x 0.50x 0.50x
copies/μl 2.0 2.0 10
(a) Standard QPCR:
maximal replicates 9+1 9+1 9+1
input volume 5 μl 5 μl 5 μl
final volume 20 μl 20 μl 20 μl
amplification factor 0.25x 0.25x 0.25x
copies/well 10 10 50
(b) High-volume QPCR:
maximal replicates 4+1 4+1 4+1
input volume 20 μl 20 μl 20 μl
final volume 50 μl 50 μl 50 μl
amplification factor 0.4x 0.4x 0.4x
copies/well 40 40 200
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